Access to this article is restricted until 12 months after publication by request of the publisher.. Restriction lift date: 2020-07-09
Synthesis and anticancer activity of novel bisindolylhydroxymaleimide derivatives with potent GSK-3 kinase inhibition
Loading...
Files
Accepted version
Supporting information
Date
2018-07-09
Authors
Winfield, Hannah J.
Cahill, Michael M.
O'Shea, Kevin D.
Pierce, Larry T.
Robert, Thomas
Ruchaud, Sandrine
Bach, Stéphane
Marchand, Pascal
McCarthy, Florence O.
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Published Version
Abstract
Synthesis and biological evaluation of a series of novel indole derivatives as anticancer agents is described. A bisindolylmaleimide template has been derived as a versatile pharmacophore with which to pursue chemical diversification. Starting from maleimide, the introduction of an oxygen to the headgroup (hydroxymaleimide) was initially investigated and the bioactivity assessed by screening of kinase inhibitory activity, identifying substituent derived selectivity. Extension of the hydroxymaleimide template to incorporate substitution of the indole nitrogens was next completed and assessed again by kinase inhibition identifying unique selectivity patterns with respect to GSK-3 and CDK kinases. Subsequently, the anticancer activity of bisindolylmaleimides were assessed using the NCI-60 cell screen, disclosing the discovery of growth inhibitory profiles towards a number of cell lines, such as SNB-75 CNS cancer, A498 and UO-31 renal, MDA MB435 melanoma and a panel of leukemia cell lines. The potential for selective kinase inhibition by modulation of this template is evident and will inform future selective clinical candidates.
Description
Keywords
Bisindolylmaleimide , Kinase screening , Maleimide substitution , Drug discovery , NCI anticancer screen
Citation
Winfield, H. J., Cahill, M. M., O'Shea, K. D., Pierce, L. T., Robert, T., Ruchaud, S., Bach, S., Marchand, P. and McCarthy, F. O. (2018) 'Synthesis and anticancer activity of novel bisindolylhydroxymaleimide derivatives with potent GSK-3 kinase inhibition', Bioorganic & Medicinal Chemistry, 26(14), pp. 4209-4224. doi: 10.1016/j.bmc.2018.07.012